ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada · Delayed Price · Currency is CAD 0.6500
0.00 (0.00%)
At close: Nov 27, 2025
ZYUS Life Sciences Revenue
ZYUS Life Sciences had revenue of 105.00K CAD in the quarter ending September 30, 2025, a decrease of -14.63%. This brings the company's revenue in the last twelve months to 465.00K, up 2.88% year-over-year. In the year 2024, ZYUS Life Sciences had annual revenue of 481.00K with 37.04% growth.
Revenue (ttm)
465.00K
Revenue Growth
+2.88%
P/S Ratio
111.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 481.00K | 130.00K | 37.04% |
| Dec 31, 2023 | 351.00K | 53.00K | 17.79% |
| Dec 31, 2022 | 298.00K | 91.00K | 43.96% |
| Dec 31, 2021 | 207.00K | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |